Ken Fisher Biomarin Pharmaceutical Inc Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q4 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 13,966 shares of BMRN stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,966
Previous 13,546
3.1%
Holding current value
$1.01 Million
Previous $952,000
3.68%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.64 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.4 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.31 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$1.07 Billion0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$938 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $13.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...